Detailed price information for Pyxis Oncology Inc (PYXS-Q) from The Globe and Mail including charting and trades.
Bio-Techne expands 3D stem cell and organoid culture portfolio with a fully defined synthetic alternative: Minneapolis Tuesday, February 3, 2026, 17:00 Hrs [IST] Bio-Techne Corpor ...
The global amniotic products market is projected to grow at a CAGR of approximately 8%, reaching nearly USD 1 billion by 2031 ...
Global Scaffold Technology Market OverviewThe global scaffold technology market is poised for robust expansion, registering an estimated growth rate of around 13% over the next five years, driven by ...
Parker Foot and Ankle, led by foot and ankle specialist Robert Parker, DPM, FACFAS, FAENS, in collaboration with Regenative ...
Multiple Independent Molecular Signals Converge to Validate GRI-0621 as a Potential Disease-Modifying Therapy LA JOLLA, CA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or ...
Multiple Independent Molecular Signals Converge to Validate GRI-0621 as a Potential Disease-Modifying Therapy LA JOLLA, CA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio" or ...
Gastric and esophageal cancers rank among the deadliest cancers Worldwide, due to their biological complexity, late diagnosis, and limited response to ...
The peptide known as SNAP-8 (acetyl octapeptide-3) has intrigued the scientific community with a molecular design that suggests a potential to modulate neuromuscular communication pathways via SNARE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results